Viewing Study NCT04156620


Ignite Creation Date: 2025-12-25 @ 4:25 AM
Ignite Modification Date: 2026-02-25 @ 5:52 PM
Study NCT ID: NCT04156620
Status: COMPLETED
Last Update Posted: 2024-06-18
First Post: 2019-10-08
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA
Sponsor: Novartis Pharmaceuticals
Organization: